TY - JOUR
T1 - ASLPrep
T2 - a platform for processing of arterial spin labeled MRI and quantification of regional brain perfusion
AU - the ALLFTD Consortium
AU - Adebimpe, Azeez
AU - Bertolero, Maxwell
AU - Dolui, Sudipto
AU - Cieslak, Matthew
AU - Murtha, Kristin
AU - Baller, Erica B.
AU - Boeve, Bradley
AU - Boxer, Adam
AU - Butler, Ellyn R.
AU - Cook, Phil
AU - Colcombe, Stan
AU - Covitz, Sydney
AU - Davatzikos, Christos
AU - Davila, Diego G.
AU - Elliott, Mark A.
AU - Flounders, Matthew W.
AU - Franco, Alexandre R.
AU - Gur, Raquel E.
AU - Gur, Ruben C.
AU - Jaber, Basma
AU - McMillian, Corey
AU - Apostolova, Liana
AU - Appleby, Brian
AU - Barmada, Sami
AU - Bordelon, Yvette
AU - Botha, Hugo
AU - Boxer, Adam L.
AU - Bozoki, Andrea
AU - Brushaber, Danielle
AU - Clark, David
AU - Coppola, Giovanni
AU - Darby, Ryan
AU - Dickson, Dennis
AU - Domoto-Reilly, Kimiko
AU - Faber, Kelley
AU - Fagan, Anne
AU - Fields, Julie A.
AU - Gavrilova, Ralitza
AU - Gendron, Tania
AU - Graff-Radford, Jonathon
AU - Graff-Radford, Neill
AU - Jones, David T.
AU - Kantarci, Kejal
AU - Knopman, David
AU - Kremers, Walter
AU - Lapid, Maria
AU - Petrucelli, Leonard
AU - Rademakers, Rosa
AU - Savica, Rodolfo
AU - Wszolek, Zbigniew
N1 - Funding Information:
We acknowledge the support of the following grants: nos. RF1MH121867 (O.E., R.A.P., T.D.S., M.M.), R01MH120482 (T.D.S. and M.M.), R01EB022573 (C.D. and T.D.S.), F31MH126569 (D.Z.), R01MH123550 (T.D.S.), T32MH019112 (E.B.B. and R.E.G.), R01MH120811 (D.J.O.), R01MH112847 (T.D.S.), R01MH112070 (C.D.), RF1AG054409 (C.D.), U01AG052943 (C.M.), U19AG063911 (B.B. and H.R.), AG062422 (H.R.), AG045333 (H.R.), AG019724 (H.R.), P01AG066597 (C.M.), P41EB015893 (J.A.D.), R01MH111886 (D.J.O.), R01MH119219 (R.E.G. and R.C.G.), R01AG054519 (J.S.P.), K01AG061277 (J.S.P.), R01MH120174 (D.R.R.), R01MH119185 (D.R.R.), R03AG063213 (S.D.), R01NS111115 and P30AG072979 (J.A.D.), and the Swiss National Science Foundation - Ambizione 185872 (O.E.). Support was provided by the Dutch Heart Foundation (2020T049; H.J.M.M.M.), by the Eurostars-2 joint program (H.J.M.M.M.) with cofunding from the European Union Horizon 2020 research and innovation program (ASPIRE E!113701) provided by the Netherlands Enterprise Agency (RvO), the EU Joint Program for Neurodegenerative Disease Research provided by the Netherlands Organization for health Research and Development and Alzheimer Nederland (DEBBIE JPND2020-568-106; H.J.M.M.M.), and the AE foundation (T.D.S.). Additional support was provided by the Center for Biomedical Image Computing and Analytics (CBICA; A.A., M.C., T.D.S. and C.D.) the Penn-CHOP Lifespan Brain Institute (LiBI; T.D.S., R.C.G. and R.E.G.).
Funding Information:
We acknowledge the support of the following grants: nos. RF1MH121867 (O.E., R.A.P., T.D.S., M.M.), R01MH120482 (T.D.S. and M.M.), R01EB022573 (C.D. and T.D.S.), F31MH126569 (D.Z.), R01MH123550 (T.D.S.), T32MH019112 (E.B.B. and R.E.G.), R01MH120811 (D.J.O.), R01MH112847 (T.D.S.), R01MH112070 (C.D.), RF1AG054409 (C.D.), U01AG052943 (C.M.), U19AG063911 (B.B. and H.R.), AG062422 (H.R.), AG045333 (H.R.), AG019724 (H.R.), P01AG066597 (C.M.), P41EB015893 (J.A.D.), R01MH111886 (D.J.O.), R01MH119219 (R.E.G. and R.C.G.), R01AG054519 (J.S.P.), K01AG061277 (J.S.P.), R01MH120174 (D.R.R.), R01MH119185 (D.R.R.), R03AG063213 (S.D.), R01NS111115 and P30AG072979 (J.A.D.), and the Swiss National Science Foundation - Ambizione 185872 (O.E.). Support was provided by the Dutch Heart Foundation (2020T049; H.J.M.M.M.), by the Eurostars-2 joint program (H.J.M.M.M.) with cofunding from the European Union Horizon 2020 research and innovation program (ASPIRE E!113701) provided by the Netherlands Enterprise Agency (RvO), the EU Joint Program for Neurodegenerative Disease Research provided by the Netherlands Organization for health Research and Development and Alzheimer Nederland (DEBBIE JPND2020-568-106; H.J.M.M.M.), and the AE foundation (T.D.S.). Additional support was provided by the Center for Biomedical Image Computing and Analytics (CBICA; A.A., M.C., T.D.S. and C.D.) the Penn-CHOP Lifespan Brain Institute (LiBI; T.D.S., R.C.G. and R.E.G.).
Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer Nature America, Inc.
PY - 2022/6
Y1 - 2022/6
N2 - Arterial spin labeled (ASL) magnetic resonance imaging (MRI) is the primary method for noninvasively measuring regional brain perfusion in humans. We introduce ASLPrep, a suite of software pipelines that ensure the reproducible and generalizable processing of ASL MRI data.
AB - Arterial spin labeled (ASL) magnetic resonance imaging (MRI) is the primary method for noninvasively measuring regional brain perfusion in humans. We introduce ASLPrep, a suite of software pipelines that ensure the reproducible and generalizable processing of ASL MRI data.
UR - http://www.scopus.com/inward/record.url?scp=85131902855&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85131902855&partnerID=8YFLogxK
U2 - 10.1038/s41592-022-01458-7
DO - 10.1038/s41592-022-01458-7
M3 - Article
C2 - 35689029
AN - SCOPUS:85131902855
VL - 19
SP - 683
EP - 686
JO - PLoS Medicine
JF - PLoS Medicine
SN - 1549-1277
IS - 6
ER -